Terns Pharmaceuticals Inc...

NASDAQ: TERN · Real-Time Price · USD
7.07
0.30 (4.43%)
At close: Aug 15, 2025, 3:59 PM
7.12
0.78%
After-hours: Aug 15, 2025, 06:54 PM EDT

Terns Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a 1M
Cost of Revenue
n/a 881K 1.03M 512K
Gross Profit
n/a -881K -1.03M 488K
Operating Income
-101.87M -102.56M -62.03M -49.86M
Interest Income
13.29M 12.9M 2.11M 170K
Pretax Income
-88.59M -89.97M -59.99M -49.65M
Net Income
-88.85M -90.21M -60.34M -50.16M
Selling & General & Admin
31.76M 39.06M 22.41M 19.55M
Research & Development
70.11M 63.5M 39.62M 31.31M
Other Expenses
n/a n/a -68K 40K
Operating Expenses
101.87M 102.56M 62.03M 50.86M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
n/a 102.56M 62.03M 50.86M
Income Tax Expense
260K 239K 358K 508K
Shares Outstanding (Basic)
79.51M 71.26M 36.03M 25.27M
Shares Outstanding (Diluted)
79.51M 71.26M 36.03M 25.27M
EPS (Basic)
-1.12 -1.27 -1.67 -1.98
EPS (Diluted)
-1.12 -1.27 -1.67 -1.98
EBITDA
-87.7M -102.27M -58.95M -49.35M
EBIT
-88.59M -102.56M -62.03M -49.86M
Depreciation & Amortization
896K 292K 1.03M 512K